Literature DB >> 1238954

Idiopathic polyneuropathy associated with cytotoxic anti-neuroblastoma serum. IgG and IgM immunoglobulin studies.

R N Rosenberg, M H Aung, R S Tindall, S Molenich, R Baskin, J D Capra, H R Toben.   

Abstract

Serums from six patients with progressive idiopathic acute or chronic polyneuropathy possessed a cytolytic activity against transformed mouse cholinergic or noncholinergic neuroblasts but not against transformed rat astrocytes. This activity was not qualitatively nor quantitatively present in serums from normal controls or from patients with a variety of other motor system disorders and other neurologic disorders. Fluorescein conjugated goat antihuman IgG and IgM monospecific immunoglubulins were used to characterize further the cytotoxic activity from patient serums and these studies suggested the presence of immunoglobulin G (IgG) and immunoglobulin M (IgM) directed against a cell surface neuroblastoma antigen. Cold reactive immunoglobulins of the IgG and IgM type were present in the serums of all six patients. A bioassay is described that may be helpful in evaluating other patients with progressive idiopathic polyneuropathies.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1238954     DOI: 10.1212/wnl.25.12.1101

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  Immunology of Guillain-Barré syndrome.

Authors:  I Steiner; O Abramsky
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Isoelectric focusing and quantitative estimation of cerebrospinal fluid and serum IgG in idiopathic polyneuropathy.

Authors:  P Livrea; G B Zimatore; I L Simone; M Trojano; V Lepore; V Ferrara; F A Lupo; D Pedone
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

3.  [Dissecting aneurysm of the anterior cerebral artery and Guillain-Barré-syndrome during pregnancy (author's transl)].

Authors:  P Pilz
Journal:  J Neurol       Date:  1977-03-21       Impact factor: 4.849

4.  Sensory neuronopathy and small cell lung cancer: antineuronal antibody reacting with neuroblastoma cells.

Authors:  K O Lövblad; J Boucraut; S Bourdenet; D Burger; D Bernard; F Regli; A J Steck
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

5.  Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.

Authors:  C L Koski; R Humphrey; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.